Product characteristics influence efficacy
In addition to the final efficacy, both studies measured the kinetics of the efficacy during the treatment period, i.e. how fast the products kill most of the mites. Again, under the warm conditions in Central and Southern Italy, all three products reached many mites already in the first week. Under the cooler conditions in Northern Italy and Germany though, Apiguard started only very slowly and killed only about 10% of the varroa mites within the first week of the treatment. Thymovar and ApiLifeVar, in this short period, already killed 30-35% of the mites in Italy and 30-40% in Germany.
In this context, it is important to understand the conditions for treatment success with thymol. As already mentioned, this substance acts by its vapors. The concentration in the hive air must be high enough to kill the varroa mites, but low enough not to harm the bees. This concentration ranges between 5-15 µg/1 hive air. Tests in Switzerland showed that Apiguard, under cooler conditions, did not reach this therapeutic concentration. It remained under 4µg/1 hive air, which explains the only low efficacy on cooler sites. Thymovar and ApiLifeVar on the other hand reached the therapeutic concentration already in the first week of the treatment. Interestingly, the hive air concentration decreased during this week in treatments with Thymovar, while it slightly increased using ApiLifeVar.
Of all three products, ApiLifeVar was the most independent of environmental conditions. The efficacy remained over 90% at all sites. This may be due to the different composition of this product: unlike the other two, it is a blend of thymol with menthol, eucalyptol and camphor. An interesting property of this blend is that it remains liquid at colder temperatures. Pure thymol is solid until a temperature of
49-51°C, therefore also under hive conditions of 35°C. Mixing thymol with other aromatic substances decreases its melting point (i.e. when it becomes liquid). Both solid and liquid thymol can pass to the gaseous stage, which is necessary to reach the varroa mites on the bees. However, the step from liquid to gaseous (evaporation) is much more constant and reliable than the step from solid to gaseous (sublimation), especially under cooler temperatures. This may be the explanation for the more consistently high efficacy of ApiLifeVar under cooler climatic conditions.
Risks and side-effects of the treatment
Every medicinal product — like varroa treatments — has risks and side effects. Despite being a “natural” substance, thymol can be toxic for bees when the concentrations in the hive air are too high. This could happen, for instance, using DIY preparations with thymol crystals. The formulation of registered products helps to avoid this risk, if the label instructions are respected. On the other hand, underdosing the treatments for cost reasons may result in insufficient efficacy and subsequent colony losses.
Thymol is a fatty substance. Therefore, it may form residues in wax and enter honey by small wax particles. A recent study in Spain showed that the thymol concentrations increase significantly during the treatment, mainly in wax and honey. This is not a risk for the consumer: Thymol has a FAO GRAS status, meaning that it is “generally recognised as safe”. However, higher concentrations may change the taste of the honey. During the treatments, the concentration in honey could surpass the sensory threshold. Sensitive test participants noticed the taste even three months after treatment. These results confirm the recommendation to never treat with honey supers present. In addition, it is advisable to not mix the combs from the brood nest with those from the honey super.
It is important to note that these risks we mainly a consequence of wrong applications or of using DIY applications like pure thymol crystals or in presence of the honey super. If registered products are used according to the label instructions, the benefit of reducing the mite load clearly prevails.
|